| Nr. | Numele studiului | Status | Locatia/Locatiile studiului |
| 1 | Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (CheckMate 714) | Activ, inca nu se recruteaza | Centrul Medical Sanador, Bucharest, Romania, 010991CF Clinical Hospital Cluj-Napoca, Cluj-Napoca, Romania, 400015Sf. Nectarie Oncology Center, Craiova, Romania, 200347Institutul Regional de Oncologie Iasi, Iasi, Romania, 700483County Emergency Hospital Suceava, Suceava, Romania, 720237 |
| 2 | Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer (EAGLE) | Activ, inca nu se recruteaza | Research Site, Baia Mare, Romania, 430031Research Site, Brasov, Romania, 500152Research Site, Cluj-Napoca, Romania, 400015Research Site, Cluj, Romania, 400058Research Site, Craiova, Romania, 200347 |
| 3 | Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer | Activ, inca nu se recruteaza | SC Medisprof SRL, Cluj-Napoca, Cluj, Romania, 400058Centrul de Oncologie Sf. Nectarie SRL, Craiova, Dolj, Romania, 200347SC Oncolab SRL, Craiova, Dolj, Romania, 200385S.C. ONCOCENTER Oncologie Clinica S.R.L., Timisoara, Timis, Romania, 300166Spitalul Clinic Judetean de Urgenta Sibiu, Clinica Oncologie Medicala, Sibiu, Romania, 550245 |
| 4 | Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer (KESTREL) | Activ, inca nu se recruteaza | Research Site, Suceava, Romania, 720237 |
| 5 | Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity (IT-MATTERS) | Activ, inca nu se recruteaza | Regional Institute of Oncology IASI, Iasi, Romania, 700483Spital Clinic Judetean Mures. Targu Mures, Romania, 540072 |
| 6 | Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer (INTERLINK-1) | Recruteaza | Research Site Not yet recruiting Constanta, Romania, 900591 Research Site Not yet recruiting Suceava, Romania, 720237 |
| 7 | Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (INDUCE-4) | Recruteaza | GSK Investigational Site Recruiting Bucuresti, Romania, 021389 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Ingrid Iordan GSK Investigational Site Recruiting Cluj Napoca, Romania, 400015 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Calin Ioan Cainap GSK Investigational Site Recruiting Craiova, Romania, 200347 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Michael Schenker GSK Investigational Site Recruiting Floresti, Romania, 407280 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Andrei Ungureanu GSK Investigational Site Recruiting Iasi, Romania, 700106 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Constantin Volovat GSK Investigational Site Recruiting Otopeni, Romania, 075100 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Elena Ciubotaru GSK Investigational Site Recruiting Suceava, Romania, 720284 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Doina Elena Ganea GSK Investigational Site Recruiting Targu Mures, Romania, 540156 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Ingrid Oana Mesinschi |
| 8 | Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (INDUCE-3) | Recruteaza | GSK Investigational Site Recruiting Brasov, Romania, 500283 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Mariana Sporis GSK Investigational Site Recruiting Bucuresti, Romania, 021389 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Ingrid Iordan GSK Investigational Site Recruiting Cluj Napoca, Romania, 400015 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Calin Ioan Cainap GSK Investigational Site Recruiting Cluj-Napoca, Romania, 400015 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Tudor Eliade Ciuleanu GSK Investigational Site Recruiting Constanta, Romania, 900591 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Laura Mazilu GSK Investigational Site Recruiting Craiova, Romania, 200347 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Michael Schenker GSK Investigational Site Recruiting Floresti, Romania, 407280 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Andrei Ungureanu GSK Investigational Site Recruiting Iasi, Romania, 700106 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Constantin Volovat GSK Investigational Site Recruiting Oradea, Romania, 410469 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Ioana Adriana Puscas GSK Investigational Site Recruiting Otopeni, Romania, 075100 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Elena Ciubotaru GSK Investigational Site Recruiting Satu Mare, Romania, 440055 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Loredana Ioana Aracs-Tamas GSK Investigational Site Recruiting Suceava, Romania, 720284 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Principal Investigator: Doina Elena Ganea |
(Visited 200 times, 1 visits today)